FULGENT GENETICS, INC. Proceeds from Issuance of Debt
FULGENT GENETICS, INC. (FLGT) reported Proceeds from Issuance of Debt of $58.00 thousand for the 6-month period ending 2021-06-30, per its 10-Q filed 2022-08-04.
Discontinued › Cash Flow › Financing Activities
us-gaap:ProceedsFromIssuanceOfDebt · last filed 2023-02-28
- FULGENT GENETICS, INC. proceeds from issuance of debt for the quarter ending 2021-06-30 was $29.00K.
- FULGENT GENETICS, INC. proceeds from issuance of debt for the quarter ending 2021-03-31 was $29.00K.
- FULGENT GENETICS, INC. proceeds from issuance of debt for fiscal 2020 was $15.02M.
| Period end | Proceeds from Issuance of Debt 3 month | Proceeds from Issuance of Debt 6 month | Proceeds from Issuance of Debt 12 month |
|---|---|---|---|
| 2021-06-30 | $29.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-04 | $58.00K 10-Q · filed 2022-08-04 | |
| 2021-03-31 | $29.00K 10-Q · filed 2022-05-05 | ||
| 2020-12-31 | $15.02M 10-K · filed 2023-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIODESIX INC (BDSX) | United States | $0.312B | |
| Lumexa Imaging Holdings, Inc. (LMRI) | United States | $0.951B | |
| EXAGEN INC. (XGN) | United States | $0.212B | -5.95 |
| Freenome, Inc. (FRNM) | United States | $0.143B | |
| CASTLE BIOSCIENCES INC (CSTL) | United States | $1.074B | -37.45 |
| SERA PROGNOSTICS, INC. (SERA) | United States | $0.062B | -5.75 |
| AMERICAN SHARED HOSPITAL SERVICES (AMS) | United States | $0.010B | -5.64 |
| Advanced Biomed Inc. (ADVB) | $0.009B | ||
| Aclarion, Inc. (ACON) | United States | $0.008B | |
| BioNexus Gene Lab Corp (BGLC) | $0.004B |